Header Logo

Connection

Abdul Qadar to Clinical Trials, Phase I as Topic

Back to Details
This is a "connection" page, showing publications Abdul Qadar has written about Clinical Trials, Phase I as Topic.
Abdul Qadar
Connection Strength
0.061
Clinical Trials, Phase I as Topic
  1. Neoadjuvant/adjuvant relugolix and enzalutamide for the treatment of high-risk locally advanced prostate cancer: study protocol of the RENAPCA phase Ib trial. BMJ Open. 2026 Apr 24; 16(4):e112623.
    View in: PubMed
    Score: 0.061
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.